Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03238456 · ClinicalTrials.gov registry record · NA
Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco
A NA study, sponsored by Claremont Graduate University.
- Completed
- Registry status
- NA
- Development phase
- 278
- Enrollment target
NCT03238456: Completed NA study, sponsored by Claremont Graduate University.
NCT03238456 is a NA study that has completed, run by Claremont Graduate University. The registered enrollment target is 278 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03238456, a NA study, has completed, sponsored by Claremont Graduate University.
- COMPLETED
- Registry status
- NA
- Development phase
- 278 participants
- Enrollment target
Study Summary
The current study aimed to test a culturally tailored program designed to help Pacific Islanders (PIs) between the ages of 18 and 30 quit smoking cigarettes by using a randomized controlled trial design with one intervention group and one control group.
Primary Outcome
How many cigarettes has the participant smoked in the last 30 days?
Interventions
- BEHAVIORAL Motivating Pacifika Against Cigarettes and Tobacco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2013-07-11 |
| Est. Completion | 2015-05-31 |
| Phase | NA |
What the finished NCT03238456 record still lists
NCT03238456 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Motivating Pacifika Against Cigarettes and Tobacco is the first listed.
NCT03238456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03238456 about?
NCT03238456 is a clinical study titled "Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco". The current study aimed to test a culturally tailored program designed to help Pacific Islanders (PIs) between the ages of 18 and 30 quit smoking cigarettes by using a randomized controlled trial design with one intervention group and one control group.
What is the current status of trial NCT03238456?
This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2013-07-11. Estimated completion is 2015-05-31.
What interventions are being tested in trial NCT03238456?
The interventions under investigation include: Motivating Pacifika Against Cigarettes and Tobacco (BEHAVIORAL).
Who is sponsoring clinical trial NCT03238456?
This trial is sponsored by Claremont Graduate University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03238456's enrollment target sits among peer trials
278 382nd of 2000 higher than 1,618 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI